Comparison results
| Results: Differences General | ✘L85.8.0 | ✘A71 |
| Distinctive symptoms | Analogs | Analogs |
| Register, to see more distinctive signs of diseases and studies | 100% | — |
| Register, to see more distinctive signs of diseases and studies | — | 100% |
| keratomas | 94% | — |
| conjunctivitis | — | 69% |
| hyperkeratosis | 89% | — |
| viral conjunctivitis | — | 66% |
| warts on the hands | 69% | — |
| chronic condition | — | 64% |
| transient tachypnea of newborns | 64% | — |
| clamidiosis | — | 62% |
| warts on the face | 62% | — |
| chlamydial conjunctivitis | — | 61% |
| flat warts | 59% | — |
| blepharoconjunctivitis | — | 52% |
| keratomas on the skin | 58% | — |
| inflammation of the eyes | — | 51% |
| thin dry skin | 56% | — |
| corneal ulcer | — | 51% |
| papillomas on the body | 55% | — |
| pannus | — | 45% |
| keratinized warts | 53% | — |
| peptic ulcer | — | 44% |
| face is yellow | 53% | — |
| conjunctivitis purulent | — | 43% |
| senestopathy | 49% | — |
| keratitis | — | 43% |
| itching of the body | 48% | — |
| sand in the eyes | — | 40% |
| breathing superficial | 47% | — |
| eyes purulent discharge | — | 39% |
| cancer | 44% | — |
| red eyelids | — | 38% |
| thin skin | 42% | — |
| visual impairment | — | 37% |
| skin atrophy | 41% | — |
| inflammation of the appendages | — | 37% |
| oncology | 40% | — |
| swelling of eyelids | — | 37% |
| warts | 40% | — |
| nose eye fatigue | — | 36% |
| skin cancer | 40% | — |
| infectious eye diseases | — | 35% |
| rapid breathing | 40% | — |
| conjunctiva redness | — | 35% |
| dry skin | 39% | — |
| corneal opacity | — | 34% |
| sensations in the hands | 38% | — |
| crying during complaints | — | 33% |
| itchy skin | 36% | — |
| lacrimation | — | 33% |
| increased bleeding | 35% | — |
| heavy eyes | — | 32% |
| periods of exacerbation | 34% | — |
| red blood vessels of the eyes | — | 32% |
| feeling of bruising | 33% | — |
| discharge from the eyes | — | 31% |
| dry | 32% | — |
| blurred vision | — | 28% |
| bleeding | 31% | — |
| weakening of immunity | — | 28% |
| drug disease | 30% | — |
| beriberi | — | 28% |
| onset of illness | 30% | — |
| fighting | — | 26% |
| skin problems | 29% | — |
| zpr fatigue from the disease | — | 26% |
| clear boundaries | 38% | 28% |
| immunodeficiency | — | 25% |
| subacute condition | 33% | 25% |
| scarring | — | 25% |
| history of surgery | 27% | 20% |
| swelling | — | 23% |
| lowered | — | 21% |
| inflammation | 28% | 45% |
Instructions
Video 
|
